Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€88.29
02.11.23
-
02.12.23
-1.95%
03.12.23

Sarepta Therapeutics

Start price
Target price
Perf. (%)
€69.74
01.11.23
-
01.11.24
6.83%
11.11.23

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€55.62
31.10.23
-
31.10.24
33.94%
11.11.23

buy
Bayer AG

Start price
Target price
Perf. (%)
€40.81
31.10.23
-
31.10.24
-18.31%
20.11.23

Could be worthwhile Investment >10% per year
Future proof or reliable business model
Growths faster than the competition
Significant cyclical dependencies
buy
Merck KGaA

Start price
Target price
Perf. (%)
€137.25
30.10.23
-
30.11.23
10.27%
10.11.23

buy
Sarepta Therapeutics

Start price
Target price
Perf. (%)
€122.15
29.10.23
€150.00
31.03.26
-
30.10.23

Could be very worthwhile Investment >20% year
buy
Medtronic plc

Start price
Target price
Perf. (%)
€67.20
27.10.23
-
27.11.23
7.62%
28.11.23

buy
Bristol-Myers Squibb

Start price
Target price
Perf. (%)
€50.60
27.10.23
-
27.11.23
-11.76%
28.11.23

buy
Teva Pharmaceutical Industries Ltd ADR

Start price
Target price
Perf. (%)
€7.68
23.10.23
-
23.10.24
10.16%
06.11.23

Top 10 in its market
Future proof or reliable business model
buy
Novo Nordisk A/S ADR

Start price
Target price
Perf. (%)
€95.40
18.10.23
-
18.10.24
14.26%
06.02.24

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€568.50
11.10.23
€558.00
11.10.24
-7.48%
14.12.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€33.12
11.10.23
-
11.10.24
14.79%
12.12.23

Known brand
Could be worthwhile Investment >10% per year
buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€24.83
11.10.23
-
11.10.24
8.30%
15.11.23

buy
Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€32.22
11.10.23
-
11.10.24
0.74%
14.10.23

Fresenius Medical Care AG & Co KGaA ST

Start price
Target price
Perf. (%)
€38.99
04.10.23
€22.00
04.10.24
-16.75%
14.10.23

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
buy
Sartorius Stedim Biotech S.A.

Start price
Target price
Perf. (%)
€226.00
30.09.23
-
30.09.24
-15.49%
14.10.23

buy
Roche Holding AG ADR

Start price
Target price
Perf. (%)
€32.29
29.09.23
-
29.10.23
-2.72%
30.10.23

buy
Amgen Inc.

Start price
Target price
Perf. (%)
€246.80
19.09.23
€250.00
19.09.24
4.13%
27.09.23

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€533.50
19.09.23
€558.00
19.09.24
6.56%
11.10.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
buy
Sanofi S.A.

Start price
Target price
Perf. (%)
€101.82
16.09.23
-
16.10.23
1.69%
17.10.23

buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€555.50
15.09.23
€558.00
15.09.24
-3.96%
19.09.23

Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Coloplast A/S B

Start price
Target price
Perf. (%)
€104.50
02.09.23
-
02.09.24
-0.38%
16.09.23

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€71.72
30.08.23
-
30.08.24
4.55%
16.10.23

buy
Fresenius SE & Co. KGaA

Start price
Target price
Perf. (%)
€29.39
25.08.23
-
25.08.24
0.20%
02.09.23

buy
HCA Holdings Inc.

Start price
Target price
Perf. (%)
€248.20
19.08.23
-
19.08.24
5.40%
02.09.23